MedPath

Study of the Relationship Between Clinical and Paraclinical Markers During Situations of Cachexia and Pre-cachexia in Patients Over 70 Years With Colorectal Surgery

Not Applicable
Completed
Conditions
Colorectal Tumor
Interventions
Procedure: Biopsy of adipose and muscular tissue
Other: Blood sampling
Other: Calorimetry
Other: Impedance measure
Other: Evaluation of nutritional status
Other: Evaluation of physical performance
Other: Evaluation of muscular strength
Other: Evaluation of emotional status
Other: Evaluation of functional status
Registration Number
NCT02199912
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Cachexia associated with cancer is a grave and most of the time irreversible common situation. It seems independent from the size of the tumor or from its metastatic character. The consequences for the management of the patient are major and exceed widely the frame of the nutrition.

Undernutrition of patients with cancer is described by a decrease of the energy contributions and a loss of muscular and fat mass, leading to a progressive functional deficiency which can go to the cachectic state.

Actually, clinical criteria are proposed allowing to characterize the state of pre-cachexia but it remain too indistinct to allow an early and efficient screening and set up effective measures of prevention of the cachexia, to avoid the loss of muscular tissue and the cast iron of the energy reserves.

It is necessary to have clinical and biological markers with diagnostic aim and forecasts during the situations precedents the appearance of cachexia.

The present study will allow calibrating a longitudinal study, which could confirm the value of measures made for the diagnosis of pre-cachexia.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria
  • Aged ≥ 70 years
  • Colorectal tumor resection with/without synchronous metastases
Exclusion Criteria
  • Emergency resection of colorectal tumor
  • Unresectable colorectal tumor with/without synchronous metastases

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Patients with colorectal surgeryBlood sampling-
Patients with colorectal surgeryCalorimetry-
Patients with colorectal surgeryImpedance measure-
Patients with colorectal surgeryBiopsy of adipose and muscular tissue-
Patients with colorectal surgeryEvaluation of muscular strength-
Patients with colorectal surgeryEvaluation of functional status-
Patients with colorectal surgeryEvaluation of nutritional status-
Patients with colorectal surgeryEvaluation of physical performance-
Patients with colorectal surgeryEvaluation of emotional status-
Primary Outcome Measures
NameTimeMethod
biological and radiological markersDuring perioperative period (from date of consent until discharge from the hospital, up to 30 postoperative days)

Validated criteria of cachexia, pre-cachexia and sarcopenia are applied. Systematic preoperative measures (TNFα, leptin, ghrelin) and CT scanning of the abdomen/pelvis are performed for all patient enrolled.

Secondary Outcome Measures
NameTimeMethod
activity of the ATGLDuring perioperative period (From date of consent until discharge from the hospital, up to 30 postoperative days)

The activity of ATGL is determined by liquid scintillation counting.

metabolic phenotypeDuring perioperative period (From date of consent until discharge from the hospital, up to 30 postoperative days)

metabolic phenotype is determinated by indirect calorimetry.

loss of fat body mass and/or lean body massDuring perioperative period (From date of consent until discharge from the hospital, up to 30 postoperative days)

Lean body mass and components (intracellular water and extracellular water as well as body cell mass) were calculated by tetrapolar bioelectrical impedance analysis

Body compositionDuring perioperative period (from date of consent until discharge from the hospital, up to 30 postoperative days)

Body composition is evaluated utilizing computerized tomography(CT) images (at the third lumbar vertebral level). A muscle index is also calculated by normalizing muscle areas for height.

Trial Locations

Locations (1)

Groupement Hospitalier Sud - Service de Médecine Gériatrique

🇫🇷

Pierre Benite, France

© Copyright 2025. All Rights Reserved by MedPath